Navigation Links
Successful Dads Have Not So Successful Daughters

Dads at the top of the pecking order can rest assured that their male offspring will take after them, but it's a very different story when it comes to the daughters, especially in the case of red deer.

A new study on red deer has found that genes that may prove useful for their sons, may not have the same effects when it comes to their female offspring.

The boffins also state that though this study was carried out in deer, the same could also hold true for humans, and could explain why successful human dads don't have the same traits as them.

The research carried out on deer showed that the female offspring of the biggest and strongest stags were less successful at breeding and had fewer fawns during their lives than daughters of the not so successful males.

This caused them to theorise that some genes are designed to benefit just one gender and can handicap the other sex.

"We see this sexually antagonistic selection because the male and female deer need to fulfil different requirements in order to be successful," the New Scientist quoted lead author of the study Katharina Foerster of the University of Edinburgh, UK, as saying.

Foerster and her colleagues studied data about the deer collected over the last 40 years from the Isle of Rhum, off Scotland's west coast. Success among stags was judged on the basis of how many fawns they sired.

Loeske Kruuk, of the University of Edinburgh, said: "Natural selection means the most successful individuals pass on their genes more frequently than the losers, so more individuals should be carrying those good genes.

"As time goes on we should expect the low-quality genes to be lost, causing less variation between individuals. But we still see huge differences.

"This effect of the best males not producing the best daughters is possibly an important reason why differences remain. Maybe the idea that some
'"/>




Page: 1 2

Related medicine news :

1. Plastic Sling Has Proved Successful In Improving Aging Of The Neck
2. Successful creation of human embryos from a single parent for the first time
3. French Doctors Successfully Separate Twins Joined At Spine
4. Alzheimer’s disease trial With EVT 101 For Successfully Complete
5. Overweight Briton Underwent Successful Surgery In India Being Denied By NHS
6. First Ever Face Transplant In China Successfully Performed
7. Third Arm Removed Successfully
8. Pancreatic Cancer Surgery Successful in 80-Year-Olds
9. Australian Surgeons Successfully Conduct Worlds First Triple Organ Transplant
10. Mental Health Providers Can Be Successfully Located With Pediatricians
11. Anti-Obesity Vaccine Successful In Rats
Post Your Comments:
(Date:5/16/2008)...eclaring that Primary care medicine is in a precip...of the American College of Physicians (ACP), today... and consumers to issue a call for comprehensive r...rnists and other primary care physicians. , Dur...e medicine in the U.S., Dr. Dale and other panelis...
(Date:5/16/2008)...la., May 16 /PRNewswire-USNewswire/- "Huh, what di...mericans, particularly our,children. More than 30 ...e,significant hearing loss and the numbers are gro... school age children have some form of hearing,los...l and economic problem,is what led Kathlyn Maguire...
(Date:5/16/2008)...ndraiser Seeks to Raise $38 Million for Life-threa...-USNewswire/ -- Walkers in nearly,every state will...ay 17 and,18 -- by participating in GREAT STRIDES,...ibrosis Foundation announced today., May is Natio...is is a,life-threatening genetic disease that caus...
(Date:5/16/2008)...Urban Health Institute with 10,000 Sensual O Condo...Playboy Mansion Fundraiser, LOS ANGELES, May 16 /...,and R & B artist J Kwon known best for his hit so...presenting the Urban Health Institute (UHI) with,1...$50,000. The donation is,being made to promote the...
Breaking Medicine News(10 mins):Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Everybody in the Club Scream O! 2
...elivered a male child on Wednesday at Holtz Childr... heart disorder called Ectopia// cordis. Seven or ... defect. The baby named Naseem, was born with his...one or sternum and the protective cover for the he...
...verweight children may have sleep problems that re... study which was published in the November issue o... 25 out of 100 overweight, inactive children teste...ng, including telltale snoring. After about three...
...y will be able to answer this question within the ...nternational study called TRIGR// (Trial to Reduce...by University of Helsinki, Finland, will research ...cation may prevent type 1 diabetes later in childh...
...o strengthen fragile, aging bones may also be prot...ed by Johns Hopkins// rheumatologist Clifton Bingh...te might be used to treat osteoarthritis after not...nds in the same class of drugs, not only slowed jo...
Other Medicine News:Health News:Naseem’s Heart Put In Its Plac 2Health News:Overweight Children Tested Positive For Sleep Disorders 2Health News:Overweight Children Tested Positive For Sleep Disorders 3Health News:Can Early Nutritional Modification Prevent Type 1 Diabetes? 2Health News:Millions with Arthritis May Benefit from Bone Loss Drug 2
(Date:5/16/2008)...-- Results demonstrating that TYKERB and trastuzum...tension of progression-free survival (PFS), -- Co...inside and,outside of the HER2 receptor may create...ting activity of TYKERB alone despite patients,pr...b and chemotherapy, LONDON and PHILADELPHIA, May ...
(Date:5/16/2008)...l Biomarkers -- for Lung Cancer Diagnosis and, Ide...r of Unknown Primary ...Types With High Sensitivity and, Specificity and...ncer Results of microRNA Signature to Identify Ti...ding 90% and Specificity of 99%, REHOVOT, Israel ...
(Date:5/16/2008)...al Mechanism May Offer Novel Approach to Blood ...LEANS, May 16 /- Pharmacope...nd development of novel small,molecule therapeutic...ss,Dual Acting Receptor Antagonist (DARA), showed ...s in a Phase 2a study in patients with mild to,mod...
(Date:5/15/2008)...fficacy for Population Most Affected by Disease -,...wswire-FirstCall/ --,Bayer HealthCare Pharmaceutic... ONXX ) today announced that Nexavar(R) (sorafenib...by 47.3 percent (HR=0.68;,p-value=0.014) in patien...cellular carcinoma (HCC), or primary liver cancer ...
Breaking Medicine Technology:GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6A Patients Right to Know 3A Silver Fillings are 50 25 Mercury 5017 1A Patients Right to Know 3A Silver Fillings are 50 25 Mercury 5017 2Virus Shows Some Cancer Killing Abilities 5014 1Virus Shows Some Cancer Killing Abilities 5014 2Virus Shows Some Cancer Killing Abilities 5014 3Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 1034 1Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 1034 2Vitamin D Wont Help Prevent Most Cancers 5012 1Vitamin D Wont Help Prevent Most Cancers 5012 2Vitamin D Wont Help Prevent Most Cancers 5012 3
...aracterization and Broad,Neuroprotective Propertie...imental Therapeutics , Neurodegenerative Disease S...te for ALS That Targets Mitochondrial Proteins , M...aceutical,company specializing in the discovery an... announced today that a publication entitled,"Iden...
... AMADEO, one of the,first studies to compare the ...lockers in hypertensive patients with,diabetic ne...of Hypertension, Milan. The results from this stud...significantly greater extent,than losartan.(1) ...ess, Foothills Hospital,in Calgary, Canada said "...
Other Medicine Technology:Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 2Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 3Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: